Medicine's Rachel Pope discusses new label for menopause therapy

FDA reverses disease label on menopause therapy

NTD: Rachel Pope, associate professor of obstetrics and gynecology, discussed the FDA's recent move to remove warnings from hormone replacement therapy packaging. “Hopefully, it will reduce the fear of women using estrogen products for relief of their symptoms and they can discuss any concerns and individual risks with their health care professional instead of simply deciding not to try it because of the fear produced from the label,” said Pope.